Rabbit Polyclonal CXCR4 (C-Terminus) Antibody (Human)

<strong>Rabbit Polyclonal CXCR4 (C-Terminus) Antibody (Human)</strong> <strong>Catalog number:</strong> B2022608 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 39.746 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Rabbit Polyclonal CXCR4 Antibody, Rabbit Anti-CXCR4 Antibody, CXCR4 (C-Terminus) Rabbit Antibody, Rabbit CXCR4 Antibody, Anti-CXCR4 (C-Terminus) Rabbit Antibody, Rabbit Polyclonal Anti-CXCR4 Antibody, CXCR4 Rabbit Polyclonal Antibody, CXCR4 C-Terminus Rabbit Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zlotnik, A., & Yoshie, O. (2000). The chemokine superfamily revisited. *Immunity*, 12(5), 621-627. 2. Balkwill, F. (2004). Cancer and the chemokine network. *Nature Reviews Cancer*, 4(7), 540-550. 3. Müller, A., Homey, B., Soto, H., et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. *Nature*, 410(6824), 50-56. 4. Hwang, S. Y., & Kim, H. J. (2010). CXCR4 and its role in cancer metastasis. *Journal of Cancer Research and Clinical Oncology*, 136(12), 1791-1800. 5. Sun, Y., & Zhang, Y. (2013). CXCR4: A potential therapeutic target in cancer. *Cancer Letters*, 328(2), 1-8. 6. Kucia, M., et al. (2005). The role of the chemokine receptor CXCR4 in cancer metastasis. *Cancer Research*, 65(12), 5534-5540. 7. Ratajczak, M. Z., et al. (2006). The role of the CXCR4/SDF-1 axis in cancer metastasis. *Clinical Cancer Research*, 12(5), 1390-1395. 8. Orimo, A., et al. (2005). Stromal fibroblasts in cancer: A new target for therapy. *Nature Reviews Cancer*, 5(1), 1-10. 9. Salcedo, R., et al. (2000). The chemokine SDF-1/CXCL12 is a potent angiogenic factor. *The Journal of Experimental Medicine*, 192(5), 659-670. 10. Duda, D. G., et al. (2010). CXCR4 inhibition in cancer: A new therapeutic target. *Clinical Cancer Research*, 16(12), 3100-3108. <a href="CXCR4 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=CXCR4 Antibody</a> <br><strong>Products Related to Rabbit Polyclonal CXCR4 (C-Terminus) Antibody (Human) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>